AAA
Affinity Asset Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-100
| Closed | -$802 | – | 87 |
|
|
2024
Q2 | $802 | Buy |
+100
| New | +$802 | ﹤0.01% | 86 |
|
|
2023
Q1 | – | Sell |
-375,000
| Closed | -$2.4M | – | 72 |
|
|
2022
Q4 | $2.4M | Buy |
+375,000
| New | +$2.4M | 0.94% | 28 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 55 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 50 |
|
|
2022
Q1 | – | Sell |
-20,000
| Closed | -$382K | – | 59 |
|
|
2021
Q4 | $382K | Sell |
20,000
-130,000
| -87% | -$2.48M | 0.14% | 44 |
|
|
2021
Q3 | $3.7M | Buy |
150,000
+50,000
| +50% | +$1.23M | 0.93% | 22 |
|
|
2021
Q2 | $2.6M | Buy |
100,000
+75,400
| +307% | +$1.96M | 0.93% | 22 |
|
|
2021
Q1 | $779K | Buy |
24,600
+5,000
| +26% | +$158K | 0.26% | 46 |
|
|
2020
Q4 | $909K | Buy |
+19,600
| New | +$909K | 0.48% | 38 |
|